10x Genomics Reports First Quarter 2026 Financial Results Accessibility Statement Skip Navigation PLEASANTON, Calif., May 7, 2026 /PRNewswire/ -- 10x Genomics, Inc.(Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results for the first quarter ended March 31, 2026. Recent Updates "We had a solid start to the year, with double-digit growth in Single Cell consumables reaction volumes and double-digit growth in Spatial consumables revenue," said Serge Saxonov, Co-founder and ...